The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27569197 |
30 |
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB. |
R. C. Patel Institute of Pharmaceutical Education and Research |
27371925 |
46 |
Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. |
Birla Institute of Technology |
26318054 |
48 |
4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation. |
Birla Institute of Technology |
25129171 |
29 |
Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis. |
Institute of Technology & Science-Pilani |
25801151 |
50 |
Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors. |
Birla Institute of Technology |
25766629 |
30 |
Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain. |
Birla Institute of Technology |
25050172 |
32 |
Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing. |
Astrazeneca |
25456076 |
29 |
An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition. |
TBA |
24809953 |
28 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. |
Astrazeneca |
24088190 |
38 |
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B. |
Astrazeneca India |
24405701 |
30 |
Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy. |
Astrazeneca |
24148991 |
5 |
Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. |
Birla Institute of Technology |
18078756 |
10 |
Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. |
Birla Institute of Technology and Science |